Versant Capital Management, Inc - CARDLYTICS INC ownership

CARDLYTICS INC's ticker is CDLX and the CUSIP is 14161W105. A total of 144 filers reported holding CARDLYTICS INC in Q1 2020. The put-call ratio across all filers is 0.83 and the average weighting 0.8%.

Quarter-by-quarter ownership
Versant Capital Management, Inc ownership history of CARDLYTICS INC
ValueSharesWeighting
Q4 2023$396
-44.2%
430.0%0.00%
Q3 2023$710
+161.0%
430.0%0.00%
Q2 2023$27243
+330.0%
0.00%
Q2 2022$010
+233.3%
0.00%
Q1 2021$030.0%0.00%
Q4 2020$030.0%0.00%
Q3 2020$030.0%0.00%
Q2 2020$030.0%0.00%
Q1 2020$030.00%
Other shareholders
CARDLYTICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
Antipodean Advisors LLC 638,800$35,121,00025.43%
CAS Investment Partners, LLC 5,416,116$297,778,00019.93%
KPS Global Asset Management UK Ltd 1,218,830$67,011,00016.64%
BRIGHTLIGHT CAPITAL MANAGEMENT LP 546,131$30,026,00012.62%
PB INVESTMENT PARTNERS, L.P. 234,175$12,874,0008.75%
Oakcliff Capital Partners, LP 304,736$16,754,0008.69%
Alua Capital Management LP 1,338,359$73,583,0005.03%
683 Capital Management, LLC 1,569,000$86,264,0004.62%
BERYLSON CAPITAL PARTNERS, LLC 62,700$3,447,0004.04%
JS Capital Management LLC 807,000$44,369,0003.45%
View complete list of CARDLYTICS INC shareholders